Pharmaceuticals
Abbott to acquire Chile's CFR Pharmaceuticals in a $2.9 bn deal
17 May 2014
This is Abbott’s first multi-billion dollar deal after it spun off some of its research-based pharmaceuticals business last year
GSK’s former China head charged with bribery
14 May 2014
GSK said that some of its senior Chinese executives appeared to have broken the law
AstraZeneca snubs Pfizer’s “opportunistic” bid
13 May 2014
Botox maker Allergan rejects Valeant's $45.7-b hostile bid
12 May 2014
Allergan Inc today rejected the hostile takeover offer from Canada’s Valeant Pharmaceuticals International Inc, saying that the $45.7-billion bid substantially undervalued the company
